Charles Marshall Glover Med Lpc Ncc is categorized under Doctors in Cary, NC and active since 2011.
Charles Marshall Glover Med Lpc Ncc was established in 2011, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Doctors business, which does work in the B2C market, and is classified as a Doctors, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Charles Marshall Glover at the company’s single location by writing to 515 Keisler Drive # 104, Cary, North Carolina NC 27518 or by phoning (919) 616-8819. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Charles Marshall Glover Med Lpc Ncc |
| Contact Person: | Charles Marshall Glover |
| Address: | 515 Keisler Drive # 104, Cary, North Carolina 27518 |
| Phone Number: | (919) 616-8819 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2011 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Charles Marshall Glover Med Lpc Ncc was started in 2011 to provide professional Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Charles Marshall Glover for inquiries that concern Charles Marshall Glover Med Lpc Ncc by calling the company number (919) 616-8819, as your correspondence is most welcome. Additionally, the physical location of the single location of Charles Marshall Glover Med Lpc Ncc can be found at the coordinates 35.742327,-78.777088 as well as the street address 515 Keisler Drive # 104 in Cary, North Carolina 27518.
For its online presence, you may visit Charles Marshall Glover Med Lpc Ncc’s website at and engage with its social media outlets through on Twitter and on Facebook.